Neudle.com: "multiple sclerosis chronic progressive"

Differential
(Click to cross reference)

abdominal reflex, absent

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

advances in neurology

adverse drug reaction

alemtuzumab

Alexanders disease

Alexanders disease, adult onset

algorithm

alkylating agents

alternating rapid movement, impaired

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, diagnosis of

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

amyotrophic lateral sclerosis, prognosis

amyotrophic lateral sclerosis, treatment of

amyotrophic lateral sclerosis, work up

ANA

analgesic

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiography, cerebral, beaded vessels

angiography, cerebral, false negative

angiography, cerebral, negative

angiography, spinal

anterior interosseous neuropathy

atlanto axial dislocation, congenital

atypical

audiogram

auditory evoked brainstem potentials

autoantibodies

autoimmune disease

autonomic dysfunction

Barkhof MR criteria for MS

basal ganglia

basal ganglia, lesion of

bone marrow suppression

Borrelia burgdorferi infection

brachial neuritis

brachial plexus neuropathy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

brainstem, lesion of

brucellosis, nervous system involvement with

CAT scan, demyelinating disease

CAT scan, false negative

CAT scan, serial

cauda equina, enhancement

cavernous sinus, syndrome

central nervous system, infection of

cerebellar degeneration

cerebellar lesion

cerebral cortex

cerebral cortical atrophy

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, proteincytologic dissociation

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, recurrent

cerebrovascular accident, women

cerebrovascular disease

cervical spine

cervical spine injury

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

collapsin response mediator protein 5 IgG

coma

comorbidities

complications

compression neuropathy

concussion

conduction block

confusion

contactin associated protein like 2 antibodies

controversies in neurology

cop 1

corpus callosum

corpus callosum, lesion of

cost

cost effectiveness

CPAP

cranial nerve enhancement

cranial neuropathy

cranial neuropathy, multiple

critical care unit

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cystinuria

cytomegalovirus infection

degenerative diseases of CNS

delay in diagnosis

delirium

dementia

dementia, frontotemporal

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatitis

dermatomyositis

diagnostic criteria

diaphragmatic paralysis

diarrhea

diarrhea, bloody

diencephalon

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

distal muscle atrophy

electroencephalogram, abnormalities of

ELISA

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, recurrent

encephalopathy, Hashimoto's

encephalopathy, metabolic

endovascular therapy

enterovirus

entrapment neuropathy

epidemiology of neurology

evidence-based research

evoked potentials

eye, pain in

facial nerve palsy

facial nerve palsy, recurrent

facial weakness

facial weakness, bilateral

fistula, arterio-venous

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

fourth ventricle, floor

fundus, abnormality of

funduscopic exam

gadolinium

gag reflex, depressed

gait disorder

gait, waddling

gamma amino butyric acid-mimetic drug

gammaglobulin therapy, intravenous

geographic location

glioma

GM1 ganglioside antibodies

gray matter

Guillain Barre syndrome

hearing loss, bilateral

hearing loss, sudden, bilateral

hemangioma

hemiparesis

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

Hodgkin's disease, neurologic involvement with

hospice

human immunodeficiency virus type 1

human T-lymphotropic virus type I(HTLV-I)

hypertrophic intracranial pachymeningitis

iatrogenic neurologic disorders

imbalance

immune complexes

immune reconstitution inflammatory syndrome

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppressive agents

immunotherapy

in situ hybridization

inclusion body myositis

infantile tremor syndrome

intermittent positive pressure breathing

internet

intracerebral hemorrhage

intrathecal antispasticity drugs

Jakob-Creutzfeldt disease

Kernig's sign

laminectomy, cervical

laughing, pathologic

leg weakness, bilateral

lenticular nucleus, lesion of, bilateral

leucine rich glioma inactivated 1 antibodies

leukemia

leukodystrophy

leukoencephalopathy, differential diagnosis

level of consciousness, decreased

Lewy body disease, diffuse

Lhermitte's sign

life sustaining treatment

limbic encephalitis

lipoprotein receptor-related protein 4

lymphocytic meningoradiculitis

lymphoma

lymphoma involving CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

malignancy screen

malignancy, occult

median neuropathy

medical-legal aspects of neurology

Melkersson's syndrome

memory, impairment of

meningeal enhancement

mental status, abnormal

methotrexate

microangiopathy, brain

microangiopathy, retina

monoclonal antibodies

monoclonal gammopathy

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

morphine

motor neuron disease

motor neuron disease, juvenile form

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, disappearing lesion on

MRI, false negative

MRI, flow void, blood

MRI, functional

MRI, high signal foci on

MRI, magnetization transfer sequence

MRI, spinal cord, increased intramedullary cord signal

MRI, volumetry

multiple myeloma

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, late-onset

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple system atrophy

muscle atrophy, progressive

muscle weakness, proximal

muscular dystrophy

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, ocular

myasthenia gravis, paraneoplastic

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

myelitis

myelitis, longitudinal

myelitis, transverse

myelomalacia

myelopathy

myelopathy, ascending

myelopathy, chronic progressive

myelopathy, ischemic-due to trauma or spondylosis

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

nerve conduction studies, motor

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, incurable

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neuromuscular blockade

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, painful

neuropathy, paraneoplastic

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, vasculitic, systemic

neuroprotective agents

NMDA antagonists

numbness, generalized

nystagmus

nystagmus, vertical

ocrelizumab

old age, neurology of

onconeural antibodies

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

optic neuritis

optic neuritis, bilateral

optic neuropathy

organomegaly

oxygen therapy

pachymeningitis, cranial

paralysis, acute areflexic

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraparesis, spastic, tropical

Parkinson disease, treatment of

pathology

patient information and support

periarteritis nodosa

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

peripheral nerve, lesion of

personality change

phenylketonuria

phenylketonuria, adult onset

phrenic nerve pacemaker

physical therapy

physician assisted suicide

placebo

plasmapheresis

pleocytosis of cerebrospinal fluid

POEMS syndrome

poliomyelitis

poliomyelitis-like illness

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

posterior interosseous neuropathy

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive spinal muscular atrophy

progressive supranuclear palsy

pseudobulbar palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychomotor retardation

ptosis

ptosis, bilateral

pyramidal tract dysfunction

quadriparesis

quadriparesis, progressive

rapidly progressing neurologic illness

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

reticular activating system

retinal artery occlusion

retinal branch artery occlusion

retinal infarction

retinopathy

retrovirus

reversible neurologic disorder

sedimentation rate, elevated

seizure

sensorineural hearing loss

sensory loss

serologic testing

serologic testing of cerebrospinal fluid

seronegative

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

solitary scerlosis

spasticity

spasticity, treatment of

spinal cord, cervical

spinal cord, compression of

spinal cord, injury of

spinal cord, injury, management of

spinal cord, lesion of

spinal cord, vascular malformation of

spirochete infection

spondylosis

stem cell tourism

stem cell transplantation

steroid

steroid therapy, CNS treatment and complications with

stiff legs

stiff man syndrome

strokelike episodes

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

Susac's syndrome

sweet taste

syphilis, diagnosis and treatment

syringomyelia

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of

thalamus, lesion of-bilateral

thoracic outlet syndromes

tongue, fasciculations of

tongue, impaired movements of

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient ischemic attack

transient neurologic deficit

treatment of neurologic disorder

tremor

tuberculosis

tumefactive lesion

tumor necrosis factor

viral infection, reactivation

vision loss, sequential

visual evoked response

visual loss

visual loss, progressive

visual loss, sudden

Waldenstrom's macroglobulinemia

walking frame

walking, difficulty with

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

X-linked bulbospinal neuronopathy

Showing articles 0 to 50 of 7343 Next >>

Acute Flaccid Myelitis: Cause, Diagnosis, and Management
Lancet 394:334-397, Murphy, O.C.,et al, 2021

Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist
AJNR 42:998-1007, Oldan, J.D.,et al, 2021

Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020

Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020

Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019

Diagnostic Tools for Immune Causes of Encephalitis
Clin Microbiol Infect 25:431-436, Lascano, A.M.,et al, 2019

Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018

Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017

A 50-year-old Woman with SLE and a Tumefactive Lesion
Neurol 89:e140-e145, Choi, J.H.,et al, 2017

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Neuromyelitis Optica Spectrum Disorders
UpToDate, May, Glisson,C.C., 2016

Responsibilities of Health Care PRofessionals in Counseling and Educating Patients with Incurable Neurological Diseases Regarding "Stem Cell Tourism"
JAMA Neurol 72:1342-1345, Bowman, M.,et al, 2015

Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Solitary Sclerosis
Neurol 78:540-544, Schmalstieg,W.F.,et al, 2012

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011

Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types
AJNR 31:541-548, 390, Vrenken,H.,et al, 2010

Diffusely Abnormal White Matter in Chronic Multiple Sclerosis: Imaging and Histopathologic Analysis
Arch Neurol 66:601-609, Seewann,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Cortical Lesions in Primary Progressive Multiple Sclerosis: A 2-Year Longitudinal MR Study
Neurol 72:1330-1336, Calabrese,M.,et al, 2009

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Curable Cause of Paraplegia: Spinal Dural Arteriovenous Fistulae
Stroke 39:2756-2759, Aghakhani,N.,et al, 2008

What Are the Prospects of Stem Cell Therapy for Neurology?
BMJ 337:1325-1327, Chandran,S., 2008

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder
Brain 129:3150-3164, Jellema, K., et al, 2006

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001

The Prevalence of Sjogren Syndrome in Patients with Primary Progressive Multiple Sclerosis
Neurol 57:1359-1363,1357, de Seze,J.,et al, 2001

Phenylketonuria Presenting in Adulthood as Progressive Spastic Paraparesis With Dementia
JNNP 71:795-797, Kasim,S.,et al, 2001

The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001

Showing articles 0 to 50 of 7343 Next >>